These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 23642068)
1. A comment on pluripotent stem cells in next-generation biomedical theranostics. Rossbach M Curr Mol Med; 2013 Jun; 13(5):879-83. PubMed ID: 23642068 [TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine. Shtrichman R; Germanguz I; Itskovitz-Eldor J Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060 [TBL] [Abstract][Full Text] [Related]
3. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing. Yin X; Li Q; Shu Y; Wang H; Thomas B; Maxwell JT; Zhang Y J Biomed Sci; 2024 May; 31(1):47. PubMed ID: 38724973 [TBL] [Abstract][Full Text] [Related]
4. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells in regenerative medicine and disease modeling. Walmsley GG; Hyun J; McArdle A; Senarath-Yapa K; Hu MS; Chung MT; Wong VW; Longaker MT; Wan DC Curr Stem Cell Res Ther; 2014 Mar; 9(2):73-81. PubMed ID: 24359141 [TBL] [Abstract][Full Text] [Related]
6. Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. Sayed N; Liu C; Wu JC J Am Coll Cardiol; 2016 May; 67(18):2161-2176. PubMed ID: 27151349 [TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells as a next-generation biomedical interface. Hankowski KE; Hamazaki T; Umezawa A; Terada N Lab Invest; 2011 Jul; 91(7):972-7. PubMed ID: 21555998 [TBL] [Abstract][Full Text] [Related]
8. Exploiting pluripotency for therapeutic gain. Deng W Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198 [TBL] [Abstract][Full Text] [Related]
10. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association. Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC; Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173 [TBL] [Abstract][Full Text] [Related]
11. Accelerating progress in induced pluripotent stem cell research for neurological diseases. Ito D; Okano H; Suzuki N Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850 [TBL] [Abstract][Full Text] [Related]
12. Application of induced pluripotent stem cell technology for the investigation of hematological disorders. Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008 [TBL] [Abstract][Full Text] [Related]
14. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons. Qi SD; Smith PD; Choong PF ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037 [TBL] [Abstract][Full Text] [Related]
15. Human stem cell research and regenerative medicine--present and future. Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982 [TBL] [Abstract][Full Text] [Related]
16. iPSCs, aging and age-related diseases. Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583 [TBL] [Abstract][Full Text] [Related]
17. Is Human-induced Pluripotent Stem Cell the Best Optimal? Wang F; Kong J; Cui YY; Liu P; Wen JY Chin Med J (Engl); 2018 Apr; 131(7):852-856. PubMed ID: 29578130 [TBL] [Abstract][Full Text] [Related]